Pfizer CEO Albert Bourla, Ph.D., has pulled back the curtain on his $1.25 billion bet on a PD-1xVEGF bispecific, revealing ...

As President Donald Trump vows to bridge the drug pricing gap between the U.S. and other developed countries with his “most ...

Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services terminated a contract with drugmaker Moderna to develop an mRNA bird flu ...

The decision of the General Court of the European Union in the Pfizergate case would allow the European Commission to ...

Albert Bourla said Pfizer is being "frugal" with investments because of the uncertainty surrounding tariffs.

CEO Albert Bourla has reportedly said that the company has made no commitments during its meeting with the Trump ...

Pfizer Inc. (NYSE:PFE) is one of the best wide moat stocks to buy now. On June 9, Pfizer, along with other drug manufacturers ...

Some social media users claim another high-profile healthcare figure is also stepping down: Pfizer CEO Albert Bourla. "Pfizer CEO Albert Burla (sic) is stepping down and now says the mRNA ...

Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no ...

When a novel coronavirus struck in early 2020, Pfizer’sPFE1.47%increase; green up pointing triangle chief executive, Dr. Albert Bourla, saw an opportunity to help save the world. He pushed the ...

Pfizer's Ceo Albert bourla says 1/4 vaccination would be necessary in order to keep hospitalizations low and illness is mild. In an interview with face the nation bourla explained why it would be ...